|
From research to collaboration to securing partnerships with
industry, the NCE accomplished much in 2003-2004. Here is a small
sample:
March, 2004
The Canadian Network for Vaccines and Immunotherapeutics
(CANVAC) announces the start of a therapeutic HIV vaccine
trial – the first clinical trial designed by academic Canadian
researchers.
February, 2004
The Canadian Language and Literacy Research Network,
with the National Literacy Secretariat, awards $119,000 for two
researchers to help improve children's literacy levels in Aboriginal
communities in Prince Edward Island and Nova Scotia.
AquaNet and Fiskeriforskning, a world-class Norwegian
aquaculture research institute, sign a three-year agreement to exchange
scientists and work collaboratively.
January, 2004
An aquatic robot that can monitor underwater life and observe changes
to a ship or oil platforms undergoes first tests, funded largely
by the Institute for Robotics and Intelligent Systems (IRIS).
November, 2003
A team of McGill University scientists, led by an investigator of
the Canadian Genetic Diseases Network (CGDN), announces
a discovery in the fight against malaria — a genetic mutation
that appears to prevent the malarial parasite from growing in red
blood cells.
Allan Rock, Industry Minister, announces that Canada will invest
$22.2 million in a new Network of Centres of Excellence –
the Advanced Foods and Materials Network (AFMNet).
The Canadian Institute for Photonic Innovations (CIPI),
co-hosts Canada's first biophotonics primer and workshop, called
BioLIGHT, for academic and industry researchers interested in developing
and applying advanced photonics technologies.
The Canadian Arthritis Network (CAN), with the
Canadian Institutes of Health Research's Institute of Musculoskeletal
Health and Arthritis announces $4.4 million in funding for
osteoarthritis research projects.
October, 2003
The Geomatics for Informed Decisions Network (GEOIDE)
Network organizes a workshop on Airborne Techniques to Measure Coast
Erosion for the Canadian Coastal Conference, and one on Sensor-Web
Networks for Environmental Applications for the Remote Sensing Symposium.
September, 2003
The Sustainable Forest Management Network (SFM)
publishes Towards Sustainable Management of the Boreal Forest,
a 1,000-page book summarizing seven years of peer-reviewed ecological,
economic and social research.
Leading international researchers convene in Banff, Alberta to
exchange the latest knowledge about SARS and work together to determine
future collaborative research topics. The event is jointly supported
and coordinated by the Mathematics of Information Technology
and Complex Systems (MITACS) Network and the Pacific Institute
for Mathematical Sciences.
Dr. Aftab A. Mufti, President of the Intelligent Sensing
for Innovative Structures (ISIS) Network outlines "Civionics,"
the meshing of electronics with the design of civil structures,
at conferences in Japan and Italy.
August, 2003
Allan Rock, Minister of Industry, announces Canada will invest $25.7 million
over the next four years in ArcticNet, a new Canadian
Network of Centres of Excellence.
July, 2003
Micronet announces four new partnerships: Cognio
Canada Inc., Discera Inc., IDEE Technologies Inc. and Macroblock
Inc.
June, 2003
A research team led by a Stem Cell Network (SCN)
investigator publishes a groundbreaking study that demonstrates
how a novel population of adult stem cells resident in muscle tissue
plays an important role in muscle regeneration.
The Protein Engineering Network (PENCE Inc.) and
CANVAC are named to a public and private sector consortium
for research on Severe Acute Respiratory Syndrome.
May, 2003
The Canadian Stroke Network (CSN) invests $1.5 million
in research to improve recovery from stroke, including $700,000
for the creation of a national "gold standard" for post-stroke
rehabilitation.
April, 2003
Research sponsored by the Canadian Bacterial Diseases Network
(CBDN) forms the basis of a multiparty licence and a collaborative
research agreement with Bioniche Animal Health Canada Inc. for the
commercial development of a vaccine to prevent disease in cattle
caused by Haemophilus somnus bacteria.
|
